Clinical Trials

Study Title:
Phase II Trial of Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma

For more information about the trial above please contact the study team:

Medical University of South Carolina
Principal Investigator, Jacqueline Kraveka, at kravekjm@musc.edu.
Study Coordinator, Hannah Kinder, at kinderh@musc.edu.

Trial opened at the following institutions: Medical University of South Carolina